Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
17.08
+0.59 (3.58%)
At close: Apr 28, 2026, 4:00 PM EDT
17.08
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Nurix Therapeutics Employees
Nurix Therapeutics had 317 employees as of November 30, 2025. The number of employees increased by 31 or 10.84% compared to the previous year.
Employees
317
Change (1Y)
31
Growth (1Y)
10.84%
Revenue / Employee
$226,432
Profits / Employee
-$931,483
Market Cap
1.77B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Nov 30, 2025 | 317 | 31 | 10.84% |
| Nov 30, 2024 | 286 | 2 | 0.70% |
| Nov 30, 2023 | 284 | -13 | -4.38% |
| Nov 30, 2022 | 297 | 55 | 22.73% |
| Nov 30, 2021 | 242 | 107 | 79.26% |
| Nov 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 29, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Vericel | 398 |
| Vir Biotechnology | 367 |
| Nuvation Bio | 298 |
| Harmony Biosciences Holdings | 293 |
| Innoviva | 159 |
| AnaptysBio | 104 |
| AtaiBeckley | 99 |
| Rapport Therapeutics | 84 |
NRIX News
- 6 days ago - Nurix Therapeutics Announces New Preclinical Data Highlighting Breadth of Targeted Protein Degradation Pipeline at AACR 2026 - GlobeNewsWire
- 15 days ago - Nurix Therapeutics Transcript: 25th Annual Needham Virtual Healthcare Conference - Transcripts
- 20 days ago - Nurix Therapeutics Reports First Quarter 2026 Financial Results and Provides a Corporate Update - GlobeNewsWire
- 21 days ago - Nurix Therapeutics to Participate in Upcoming Investor Conference - GlobeNewsWire
- 5 weeks ago - Nurix Therapeutics Announces Multiple Presentations Showcasing Depth of Research Pipeline and Scientific Leadership at the American Association for Cancer Research (AACR) 2026 Annual Meeting - GlobeNewsWire
- 2 months ago - Nurix Therapeutics Transcript: Piper Sandler Virtual Novel Targets in Immunology Symposium - Transcripts
- 3 months ago - Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides a Corporate Update - GlobeNewsWire
- 3 months ago - Nurix Therapeutics Transcript: 44th Annual J.P. Morgan Healthcare Conference - Transcripts